The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes
Open accessAbstract
Background: Systemic administration of linear polyethylenimine–DNA complexes (L‐PEI/DNA) results in transient expression of the transgene in the lung. This study analyzes the side‐effects associated with L‐PEI‐mediated transfection. Methods: Mice weighing from 16 to 25 g received increasing amounts of L‐PEI/DNA intravenously. Gene expression was evaluated using luciferase as a reporter gene. Toxicity was evaluated by monitoring the appearance of shock after injection, the survival of the animals, and the microscopic damage in the tissues. Adherence of blood cells and endothelium activation were observed after CD11‐b and von Willebrand immunostaining. Anti‐aggregant treatments were used in order to prevent the formation of thrombi. Results: Increasing the quantity of L‐PEI/DNA resulted in a marked augmentation of the luciferase activity in the lung, but was associated with liver necrosis and death. Lethality was reached at lower doses in older mice, suggesting an age influence. Transfection was associated with activation of the lung endothelium and increased adhesion of small aggregates containing platelets and CD11‐b‐positive cells, without the appearance of large thrombi and of lung injury. Anti‐aggregant treatments (aspirin, EDTA, heparin or clopidogrel) decreased the L‐PEI‐mediated transfection, supporting the hypothesis that platelets participate in the blocking of DNA complexes in the lung capillaries. Conclusion: This study demonstrates that L‐PEI/DNA activates the lung endothelium and forms small aggregates, a side‐effect linked to the transfection efficiency. Copyright © 2001 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Improved DNA: liposome complexes for increased systemic delivery and gene expression
Templeton, N. S., Lasic, D. D., Frederik, P. M., Strey, H. H., Roberts, D. D., & Pavlakis, G. N. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-647 · Cited by 740
Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice
Zhu, N., Liggitt, D., Liu, Y., & Debs, R. (1993) · Science · doi:10.1126/science.7687073 · Cited by 720
Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J. P., & Demeneix, B. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.16-1947 · Cited by 541
Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery
Liu, Y., Mounkes, L. C., Liggitt, H. D., Brown, C. S., Solodin, I., Heath, T. D., & Debs, R. J. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-167 · Cited by 405
Polyethylenimine-based intravenous delivery of transgenes to mouse lung
Goula, D., Benoist, C., Mantero, S., Merlo, G., Levi, G., & Demeneix, B. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300717 · Cited by 375
Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery
Li, S., Rizzo, M., Bhattacharya, S., & Huang, L. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300683 · Cited by 369
Kircheis, R., Wightman, L., Schreiber, A., Robitza, B., Rössler, V, Kursa, M., & Wagner, E. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301351 · Cited by 350
Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse
Zou, S.-M., Erbacher, P., Remy, J.-S., & Behr, J.-P. (2000) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(200003/04)2:2<128::aid-jgm95>3.0.co;2-w · Cited by 317
Cited by
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Bertrand, N., & Leroux, J.-C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.098 · Cited by 707
An overview of current delivery systems in cancer gene therapy
El-Aneed, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.013 · Cited by 693
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Lächelt, U., & Wagner, E. (2015) · Chemical Reviews · doi:10.1021/cr5006793 · Cited by 600
Polymeric nanomedicine for cancer therapy
Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506
Nanomedicine in pulmonary delivery
Mansour, H., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 485
Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer
Boeckle, S., von Gersdorff, K., van der Piepen, S., Culmsee, C., Wagner, E., & Ogris, M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.598 · Cited by 447
Layer-by-Layer Assembled Gold Nanoparticles for siRNA Delivery
Elbakry, A., Zaky, A., Liebl, R., Rachel, R., Goepferich, A., & Breunig, M. (2009) · Nano Letters · doi:10.1021/nl9003865 · Cited by 425
Polyethylenimine (PEI) in gene therapy: Current status and clinical applications
Casper, J., Schenk, S. H., Parhizkar, E., Detampel, P., Dehshahri, A., & Huwyler, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.001 · Cited by 340
Chemical modification of chitosan as a gene carrier in vitro and in vivo
Kim, T.-H., Jiang, H.-L., Jere, D., Park, I.-K., Cho, M.-H., Nah, J.-W., Choi, Y.-J., Akaike, T., & Cho, C.-S. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.001 · Cited by 322
Cationic compounds used in lipoplexes and polyplexes for gene delivery
Zhang, S., Xu, Y., Wang, B., Qiao, W., Liu, D., & Li, Z. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.019 · Cited by 319
Read, M. L., Singh, S., Ahmed, Z., Stevenson, M., Briggs, S. S., Oupicky, D., Barrett, L. B., Spice, R., Kendall, M., Berry, M., et al. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni085 · Cited by 279
Gene Transfer In Vivo with DNA–Liposome Complexes: Safety and Acute Toxicity in Mice
Stewart, M. J., Plautz, G. E., Buono, L. D., Yang, Z. Y., Xu, L., Gao, X., Huang, L., Nabel, E. G., & Nabel, G. J. (1992) · Human Gene Therapy · doi:10.1089/hum.1992.3.3-267 · Cited by 264
Tang, Y., Han, S., Liu, H., Chen, X., Huang, L., Li, X., & Zhang, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.087 · Cited by 147
Metadata
- Authors
- Chollet, P., Favrot, M. C., Hurbin, A., & Coll, J.
- Venue
- The Journal of Gene Medicine
- Publisher
- Wiley
- Published
- 2001-11-29
- Volume
- 4
- Issue
- 1
- Pages
- 84-91
- ISSN
- 1099-498X (ISSN-L)
- 1521-2254
- OpenAlex
- W1998004849
- Cited by
- 373
- References
- 25
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.